James, C. D., Ahmed, A., Sonabend, A., Horbinski, C., & Stupp, R. (2018). CSIG-18. MODELING TEMOZOLOMIDE RESISTANCE WITH GLIOBLASTOMA PATIENT DERIVED XENOGRAFTS. Neuro-oncology (Charlottesville, Va.), 20(suppl_6), vi46-vi47. https://doi.org/10.1093/neuonc/noy148.184
Chicago Style (17th ed.) CitationJames, C David, Atique Ahmed, Adam Sonabend, Craig Horbinski, and Roger Stupp. "CSIG-18. MODELING TEMOZOLOMIDE RESISTANCE WITH GLIOBLASTOMA PATIENT DERIVED XENOGRAFTS." Neuro-oncology (Charlottesville, Va.) 20, no. suppl_6 (2018): vi46-vi47. https://doi.org/10.1093/neuonc/noy148.184.
MLA (9th ed.) CitationJames, C David, et al. "CSIG-18. MODELING TEMOZOLOMIDE RESISTANCE WITH GLIOBLASTOMA PATIENT DERIVED XENOGRAFTS." Neuro-oncology (Charlottesville, Va.), vol. 20, no. suppl_6, 2018, pp. vi46-vi47, https://doi.org/10.1093/neuonc/noy148.184.